Senseonics to Participate in the H.C. Wainwright Global Investment Conference
September 09 2021 - 6:59PM
Business Wire
Senseonics Holdings, Inc. (NYSE American: SENS), a medical
technology company focused on the development and commercialization
of long-term, implantable continuous glucose monitoring (CGM)
systems for people with diabetes, today announced plans to
participate in the upcoming virtual H.C. Wainwright Global
Investment Conference.
Management is scheduled to participate and hold one
on-one-meetings Wednesday, September 15, 2021. A presentation
webcast will be available at the start of the conference on Monday,
September 13, 2021, at 7:00am ET. Interested parties may access the
on-demand webcast at the same time on the “Investors” section of
the Company’s website at www.senseonics.com.
About Senseonics
Senseonics Holdings, Inc. is a medical technology company
focused on the design, development and commercialization of
transformational glucose monitoring products designed to help
people with diabetes confidently live their lives with ease.
Senseonics' CGM systems, Eversense® and Eversense® XL, include a
small sensor inserted completely under the skin that communicates
with a smart transmitter worn over the sensor. The glucose data are
automatically sent every 5 minutes to a mobile app on the user's
smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210909006192/en/
Senseonics Investor Relations Contact: Lynn Lewis or
Philip Taylor Investor Relations 415-937-5406
Investors@senseonics.com
Senseonics (AMEX:SENS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Senseonics (AMEX:SENS)
Historical Stock Chart
From Jul 2023 to Jul 2024